等待开盘 08-05 09:30:00 美东时间
-0.200
-5.73%
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从41美元升至46美元;杰富瑞:维持Kiniksa Pharmaceuticals"买入"评级,目标价从45美元升至54美元
07-30 09:36
Lake Street analyst Ben Haynor maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers the price target from $15 to $9.5.
07-30 02:13
EKSO Bionics shares are trading lower after the company reported a Q2 sales mis...
07-29 21:54
Shares of Celestica Inc. (NYSE:CLS) rose sharply in pre-market trading after th...
07-29 18:46
Companies Reporting Before The Bell • Bank of Hawaii (NYSE:BOH) is likely to re...
07-28 16:32
Ekso Bionics Holdings (NASDAQ:EKSO) is set to give its latest quarterly earning...
07-26 03:01
Ekso Bionics Holdings, Inc. will release its second-quarter 2025 financial and business results after the market close on July 28, 2025. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and recent developments. The call can be accessed via phone by dialing 877-407-6184 (domestic) or 201-389-0877 (international) and will be available live and archived on the Company’s website at www.eksobionics.com under...
07-21 20:45
Ekso Bionics launches eksoUniversity, an online platform offering continuing education courses for physical therapists and assistants. The courses, approved for CEUs in over 30 states, focus on treating neurological conditions. The platform aims to educate professionals on evolving patient care options, supporting Ekso Bionics' mission to enhance human mobility and quality of life through exoskeleton technology.
07-18 12:00
https://x.com/EksoBionics/status/1935374449596891611
06-19 00:39
Ekso Bionics (NASDAQ:EKSO) on Wednesday said that it has successfully demonstrated initial proof-of-concept in integrating artificial intelligence-enabled capabilities across its portfolio of enterpri...
06-18 20:12